Selected Publications
- Maternal PRDM10 activates essential genes for oocyte-to-embryo transition. Michelle K.Y. Seah, Brenda Y. Han, Yan Huang, Louise J.H. Rasmussen, Andrina J. Stäubli, Judith Bello-Rodríguez, Andrew Chi Ho Chan, Maxime Gasnier, Heike Wollmann, Ernesto Guccione, Daniel M. Messerschmidt. Nature Communications
- Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers. Brandon M. Lehrich, Evan R. Delgado, Tyler M. Yasaka, Silvia Liu, Catherine Cao, Yuqing Liu, Mohammad N. Taheri, Xiangnan Guan, Hartmut Koeppen, Sucha Singh, Vik Meadows, Jia Jun Liu, Anya Singh-Varma, Yekaterina Krutsenko, Minakshi Poddar, T. Kevin Hitchens, Lesley M. Foley, Binyong Liang, Alex Rialdi, Ravi P. Rai, Panari Patel, Madeline Riley, Aaron Bell, Reben Raeman, Tulin Dadali, Jason J. Luke, Ernesto Guccione, Mo R. Ebrahimkhani, Amaia Lujambio, Xin Chen, Martin Maier, Yulei Wang, Wendy Broom, Junyan Tao, Satdarshan P. Monga. Nature Communications
- Discovery of a Potent and Selective Protein Arginine Methyltransferase 5 (PRMT5) PROTAC Degrader. Yue Zhong, Huensuk Kim, Chao Qian, Ling Xie, Xian Chen, Yan Xiong, Jacqueline Hu, Matthew Chen, Ernesto Guccione, Yudao Shen, Jian Jin. Journal of Medicinal Chemistry